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Cross-sectional analytical and case-control studies are
commonly reported study designs in clinical and public
health research. Clinicians and researchers often get confused
between them. Both are analytical observational studies,
compare two study groups, and collect the data at one
time from the study participants. However, the point of
initiation of the study and interpretation of the results are
quite different.
We came across an interesting article titled “Toxoplasma
gondii Infection in Pregnant Women: A Seroprevalence and
Case-Control Study in Eastern China” by Cong et al. [1].
According to the authors, this case-control study was per-
formed to estimate the seroprevalence of T. gondii infection
in pregnant women in two regions of eastern China and to
identify associated risk factors and possible routes of con-
tamination. However, looking carefully at the study method
and reported results, this is a cross-sectional analytical study
and not a case-control study as claimed by the authors.
Seroprevalence cannot be estimated in a case-control study
as the denominator (population at risk) is not available. To
explore the risk factors of T. gondii infection in pregnant
women through a case-control study, authors should have
selected cases with the outcome (pregnant women with T.
gondii infection) and controls (pregnant women without T.
gondii infection).
Authors have studied large number of study participants
(𝑛 = 1930); however, they should have justified the sample
size. Assuming a seroprevalence of 9% among pregnant
women in the reference population and after applying con-
tinuity correction, the study would require a sample size of
675 for each group (i.e., a total sample size of 1930, assuming
equal group sizes), to achieve a power of 80% for detecting
a difference in proportions of 5% between the test and the
reference group at a two-sided 𝑃 value of 0.05 [2].
The objective of the study was to identify the risk factors
of T. gondii infection among pregnant women. However, the
independent correlation between pregnancy and T. gondii
infection is not analyzed by the authors. The applied regres-
sion model explains the independent correlates of T. gondii
infection among all the study participants (pregnant and
nonpregnant). In the result section, authors state that anti-
T. gondii IgG antibodies were found in 147 (15.2%) of 965
pregnant women and in 167 (17.3%) of 965 control subjects
(𝑃 = 0.217). The study variables were included in the
multivariate analysis if they had a 𝑃 value ≤ 0.25 in the
bivariate analysis. In viewof the study objective and𝑃 = 0.217
(i.e., less than 0.25) for pregnant versus control group, the
pregnancy status should have been included in the regression
analysis. In addition, it is always recommended to assess and
report the adequacy of applied regressionmodel. Failure to do
so may lead to misleading or incorrect inferences. Although
the study sample was very large (𝑛 = 1930), a word about 𝑅2
(explaining the variance in outcome variable) of the applied
regression model would have been more affirmative.
Nonetheless, we must congratulate the authors for inves-
tigating an important public health problem.
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